nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—psoriasis—psoriatic arthritis	0.878	1	CtDrD
Hydroxyurea—Skin exfoliation—Betamethasone—psoriatic arthritis	0.00037	0.00304	CcSEcCtD
Hydroxyurea—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.00037	0.00304	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.000366	0.003	CcSEcCtD
Hydroxyurea—Skin ulcer—Methotrexate—psoriatic arthritis	0.000363	0.00298	CcSEcCtD
Hydroxyurea—Ulcer—Prednisone—psoriatic arthritis	0.000357	0.00293	CcSEcCtD
Hydroxyurea—Diarrhoea—Auranofin—psoriatic arthritis	0.000356	0.00292	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.000353	0.0029	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.000345	0.00283	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.000345	0.00283	CcSEcCtD
Hydroxyurea—Vomiting—Auranofin—psoriatic arthritis	0.000331	0.00271	CcSEcCtD
Hydroxyurea—Rash—Auranofin—psoriatic arthritis	0.000328	0.00269	CcSEcCtD
Hydroxyurea—Dermatitis—Auranofin—psoriatic arthritis	0.000328	0.00269	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.000325	0.00266	CcSEcCtD
Hydroxyurea—Skin exfoliation—Prednisone—psoriatic arthritis	0.000323	0.00265	CcSEcCtD
Hydroxyurea—Nausea—Auranofin—psoriatic arthritis	0.000309	0.00254	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Methotrexate—psoriatic arthritis	0.000304	0.0025	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Prednisone—psoriatic arthritis	0.000301	0.00247	CcSEcCtD
Hydroxyurea—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.000299	0.00245	CcSEcCtD
Hydroxyurea—Ulcer—Methotrexate—psoriatic arthritis	0.000299	0.00245	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.000295	0.00242	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.000295	0.00242	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Methotrexate—psoriatic arthritis	0.000288	0.00236	CcSEcCtD
Hydroxyurea—Pancreatitis—Prednisolone—psoriatic arthritis	0.000286	0.00235	CcSEcCtD
Hydroxyurea—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00028	0.0023	CcSEcCtD
Hydroxyurea—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00027	0.00221	CcSEcCtD
Hydroxyurea—Weight increased—Prednisolone—psoriatic arthritis	0.000266	0.00218	CcSEcCtD
Hydroxyurea—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000263	0.00216	CcSEcCtD
Hydroxyurea—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000262	0.00215	CcSEcCtD
Hydroxyurea—Neoplasm—Methotrexate—psoriatic arthritis	0.000255	0.00209	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000255	0.00209	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.000251	0.00206	CcSEcCtD
Hydroxyurea—Weight increased—Triamcinolone—psoriatic arthritis	0.000244	0.002	CcSEcCtD
Hydroxyurea—Weight increased—Methylprednisolone—psoriatic arthritis	0.000244	0.002	CcSEcCtD
Hydroxyurea—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000239	0.00196	CcSEcCtD
Hydroxyurea—Infestation—Methylprednisolone—psoriatic arthritis	0.000239	0.00196	CcSEcCtD
Hydroxyurea—Face oedema—Prednisone—psoriatic arthritis	0.000237	0.00194	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisolone—psoriatic arthritis	0.000235	0.00193	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000235	0.00192	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000234	0.00192	CcSEcCtD
Hydroxyurea—Haemorrhage—Prednisolone—psoriatic arthritis	0.000234	0.00192	CcSEcCtD
Hydroxyurea—Hepatic failure—Methotrexate—psoriatic arthritis	0.000228	0.00187	CcSEcCtD
Hydroxyurea—Renal failure acute—Methotrexate—psoriatic arthritis	0.000222	0.00182	CcSEcCtD
Hydroxyurea—Weight increased—Betamethasone—psoriatic arthritis	0.000222	0.00182	CcSEcCtD
Hydroxyurea—Weight increased—Dexamethasone—psoriatic arthritis	0.000222	0.00182	CcSEcCtD
Hydroxyurea—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000216	0.00177	CcSEcCtD
Hydroxyurea—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000215	0.00177	CcSEcCtD
Hydroxyurea—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000215	0.00176	CcSEcCtD
Hydroxyurea—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000214	0.00176	CcSEcCtD
Hydroxyurea—Hallucination—Methylprednisolone—psoriatic arthritis	0.000213	0.00175	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000213	0.00175	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000213	0.00175	CcSEcCtD
Hydroxyurea—Pancreatitis—Prednisone—psoriatic arthritis	0.000208	0.00171	CcSEcCtD
Hydroxyurea—Erythema—Prednisolone—psoriatic arthritis	0.000203	0.00167	CcSEcCtD
Hydroxyurea—Neutropenia—Prednisone—psoriatic arthritis	0.000198	0.00163	CcSEcCtD
Hydroxyurea—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000196	0.00161	CcSEcCtD
Hydroxyurea—Haemoglobin—Betamethasone—psoriatic arthritis	0.000196	0.00161	CcSEcCtD
Hydroxyurea—Haemorrhage—Betamethasone—psoriatic arthritis	0.000195	0.0016	CcSEcCtD
Hydroxyurea—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000195	0.0016	CcSEcCtD
Hydroxyurea—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000194	0.0016	CcSEcCtD
Hydroxyurea—Hallucination—Dexamethasone—psoriatic arthritis	0.000194	0.00159	CcSEcCtD
Hydroxyurea—Hallucination—Betamethasone—psoriatic arthritis	0.000194	0.00159	CcSEcCtD
Hydroxyurea—Weight increased—Prednisone—psoriatic arthritis	0.000193	0.00158	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000189	0.00155	CcSEcCtD
Hydroxyurea—Erythema—Triamcinolone—psoriatic arthritis	0.000187	0.00153	CcSEcCtD
Hydroxyurea—Erythema—Methylprednisolone—psoriatic arthritis	0.000187	0.00153	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000185	0.00152	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—psoriatic arthritis	0.000185	0.00152	CcSEcCtD
Hydroxyurea—Malaise—Prednisolone—psoriatic arthritis	0.000183	0.0015	CcSEcCtD
Hydroxyurea—Angiopathy—Betamethasone—psoriatic arthritis	0.000177	0.00145	CcSEcCtD
Hydroxyurea—Angiopathy—Dexamethasone—psoriatic arthritis	0.000177	0.00145	CcSEcCtD
Hydroxyurea—Convulsion—Prednisolone—psoriatic arthritis	0.000176	0.00145	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—psoriatic arthritis	0.000174	0.00143	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000173	0.00142	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000173	0.00142	CcSEcCtD
Hydroxyurea—Alopecia—Dexamethasone—psoriatic arthritis	0.000172	0.00141	CcSEcCtD
Hydroxyurea—Alopecia—Betamethasone—psoriatic arthritis	0.000172	0.00141	CcSEcCtD
Hydroxyurea—Discomfort—Prednisolone—psoriatic arthritis	0.000171	0.0014	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisone—psoriatic arthritis	0.000171	0.0014	CcSEcCtD
Hydroxyurea—Haemorrhage—Prednisone—psoriatic arthritis	0.00017	0.00139	CcSEcCtD
Hydroxyurea—Erythema—Betamethasone—psoriatic arthritis	0.00017	0.00139	CcSEcCtD
Hydroxyurea—Erythema—Dexamethasone—psoriatic arthritis	0.00017	0.00139	CcSEcCtD
Hydroxyurea—Hallucination—Prednisone—psoriatic arthritis	0.000169	0.00139	CcSEcCtD
Hydroxyurea—Malaise—Triamcinolone—psoriatic arthritis	0.000169	0.00138	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—psoriatic arthritis	0.000168	0.00138	CcSEcCtD
Hydroxyurea—Malaise—Methylprednisolone—psoriatic arthritis	0.000168	0.00138	CcSEcCtD
Hydroxyurea—Oedema—Prednisolone—psoriatic arthritis	0.000166	0.00136	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—psoriatic arthritis	0.000166	0.00136	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—psoriatic arthritis	0.000166	0.00136	CcSEcCtD
Hydroxyurea—Convulsion—Triamcinolone—psoriatic arthritis	0.000162	0.00133	CcSEcCtD
Hydroxyurea—Convulsion—Methylprednisolone—psoriatic arthritis	0.000162	0.00133	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—psoriatic arthritis	0.000158	0.0013	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—psoriatic arthritis	0.000158	0.0013	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—psoriatic arthritis	0.000158	0.0013	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000158	0.00129	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000157	0.00129	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000157	0.00129	CcSEcCtD
Hydroxyurea—Discomfort—Triamcinolone—psoriatic arthritis	0.000157	0.00129	CcSEcCtD
Hydroxyurea—Discomfort—Methylprednisolone—psoriatic arthritis	0.000157	0.00129	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—psoriatic arthritis	0.000154	0.00126	CcSEcCtD
Hydroxyurea—Angiopathy—Prednisone—psoriatic arthritis	0.000154	0.00126	CcSEcCtD
Hydroxyurea—Malaise—Betamethasone—psoriatic arthritis	0.000153	0.00126	CcSEcCtD
Hydroxyurea—Malaise—Dexamethasone—psoriatic arthritis	0.000153	0.00126	CcSEcCtD
Hydroxyurea—Oedema—Triamcinolone—psoriatic arthritis	0.000153	0.00125	CcSEcCtD
Hydroxyurea—Infection—Triamcinolone—psoriatic arthritis	0.000152	0.00124	CcSEcCtD
Hydroxyurea—Infection—Methylprednisolone—psoriatic arthritis	0.000151	0.00124	CcSEcCtD
Hydroxyurea—Alopecia—Prednisone—psoriatic arthritis	0.00015	0.00123	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000149	0.00123	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000149	0.00122	CcSEcCtD
Hydroxyurea—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000148	0.00121	CcSEcCtD
Hydroxyurea—Erythema—Prednisone—psoriatic arthritis	0.000148	0.00121	CcSEcCtD
Hydroxyurea—Convulsion—Betamethasone—psoriatic arthritis	0.000147	0.00121	CcSEcCtD
Hydroxyurea—Convulsion—Dexamethasone—psoriatic arthritis	0.000147	0.00121	CcSEcCtD
Hydroxyurea—Discomfort—Dexamethasone—psoriatic arthritis	0.000143	0.00117	CcSEcCtD
Hydroxyurea—Discomfort—Betamethasone—psoriatic arthritis	0.000143	0.00117	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—psoriatic arthritis	0.000143	0.00117	CcSEcCtD
Hydroxyurea—Pain—Prednisolone—psoriatic arthritis	0.000142	0.00116	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—psoriatic arthritis	0.000142	0.00116	CcSEcCtD
Hydroxyurea—Oedema—Betamethasone—psoriatic arthritis	0.000138	0.00114	CcSEcCtD
Hydroxyurea—Oedema—Dexamethasone—psoriatic arthritis	0.000138	0.00114	CcSEcCtD
Hydroxyurea—Infection—Dexamethasone—psoriatic arthritis	0.000138	0.00113	CcSEcCtD
Hydroxyurea—Infection—Betamethasone—psoriatic arthritis	0.000138	0.00113	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000137	0.00112	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000137	0.00112	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—psoriatic arthritis	0.000137	0.00112	CcSEcCtD
Hydroxyurea—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000136	0.00112	CcSEcCtD
Hydroxyurea—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000136	0.00111	CcSEcCtD
Hydroxyurea—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000136	0.00111	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000136	0.00111	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000136	0.00111	CcSEcCtD
Hydroxyurea—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000134	0.0011	CcSEcCtD
Hydroxyurea—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000134	0.0011	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—psoriatic arthritis	0.000133	0.00109	CcSEcCtD
Hydroxyurea—Anorexia—Dexamethasone—psoriatic arthritis	0.000132	0.00108	CcSEcCtD
Hydroxyurea—Anorexia—Betamethasone—psoriatic arthritis	0.000132	0.00108	CcSEcCtD
Hydroxyurea—Fatigue—Triamcinolone—psoriatic arthritis	0.000132	0.00108	CcSEcCtD
Hydroxyurea—Fatigue—Methylprednisolone—psoriatic arthritis	0.000131	0.00108	CcSEcCtD
Hydroxyurea—Pain—Triamcinolone—psoriatic arthritis	0.00013	0.00107	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—psoriatic arthritis	0.000129	0.00106	CcSEcCtD
Hydroxyurea—Convulsion—Prednisone—psoriatic arthritis	0.000128	0.00105	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—psoriatic arthritis	0.000127	0.00104	CcSEcCtD
Hydroxyurea—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000126	0.00103	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000125	0.00103	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—psoriatic arthritis	0.000125	0.00103	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000125	0.00102	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—psoriatic arthritis	0.000124	0.00102	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—psoriatic arthritis	0.000123	0.00101	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000122	0.001	CcSEcCtD
Hydroxyurea—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000122	0.001	CcSEcCtD
Hydroxyurea—Dyspepsia—Betamethasone—psoriatic arthritis	0.000122	0.001	CcSEcCtD
Hydroxyurea—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000121	0.00099	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—psoriatic arthritis	0.000121	0.000989	CcSEcCtD
Hydroxyurea—Decreased appetite—Betamethasone—psoriatic arthritis	0.00012	0.000987	CcSEcCtD
Hydroxyurea—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00012	0.000987	CcSEcCtD
Hydroxyurea—Infection—Prednisone—psoriatic arthritis	0.00012	0.000983	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00012	0.000981	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00012	0.000981	CcSEcCtD
Hydroxyurea—Fatigue—Dexamethasone—psoriatic arthritis	0.000119	0.000979	CcSEcCtD
Hydroxyurea—Fatigue—Betamethasone—psoriatic arthritis	0.000119	0.000979	CcSEcCtD
Hydroxyurea—Pain—Dexamethasone—psoriatic arthritis	0.000118	0.000971	CcSEcCtD
Hydroxyurea—Pain—Betamethasone—psoriatic arthritis	0.000118	0.000971	CcSEcCtD
Hydroxyurea—Nervous system disorder—Prednisone—psoriatic arthritis	0.000118	0.00097	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—psoriatic arthritis	0.000117	0.000961	CcSEcCtD
Hydroxyurea—Anorexia—Prednisone—psoriatic arthritis	0.000115	0.000943	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000115	0.00094	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—psoriatic arthritis	0.000114	0.000936	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000114	0.000936	CcSEcCtD
Hydroxyurea—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000114	0.000936	CcSEcCtD
Hydroxyurea—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000112	0.000922	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000112	0.00092	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—psoriatic arthritis	0.000111	0.000913	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—psoriatic arthritis	0.000111	0.000907	CcSEcCtD
Hydroxyurea—Dizziness—Prednisolone—psoriatic arthritis	0.00011	0.0009	CcSEcCtD
Hydroxyurea—Asthenia—Triamcinolone—psoriatic arthritis	0.000109	0.000898	CcSEcCtD
Hydroxyurea—Body temperature increased—Betamethasone—psoriatic arthritis	0.000109	0.000898	CcSEcCtD
Hydroxyurea—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000109	0.000898	CcSEcCtD
Hydroxyurea—Asthenia—Methylprednisolone—psoriatic arthritis	0.000109	0.000896	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—psoriatic arthritis	0.000107	0.000878	CcSEcCtD
Hydroxyurea—Dyspepsia—Prednisone—psoriatic arthritis	0.000106	0.000871	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—psoriatic arthritis	0.000105	0.00086	CcSEcCtD
Hydroxyurea—Rash—Prednisolone—psoriatic arthritis	0.000105	0.000858	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisolone—psoriatic arthritis	0.000105	0.000858	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000104	0.000856	CcSEcCtD
Hydroxyurea—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000104	0.000855	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—psoriatic arthritis	0.000104	0.000853	CcSEcCtD
Hydroxyurea—Headache—Prednisolone—psoriatic arthritis	0.000104	0.000853	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—psoriatic arthritis	0.000104	0.000852	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—psoriatic arthritis	0.000103	0.000846	CcSEcCtD
Hydroxyurea—Dizziness—Triamcinolone—psoriatic arthritis	0.000101	0.000828	CcSEcCtD
Hydroxyurea—Dizziness—Methylprednisolone—psoriatic arthritis	0.000101	0.000826	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—psoriatic arthritis	0.0001	0.000821	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—psoriatic arthritis	9.94e-05	0.000815	CcSEcCtD
Hydroxyurea—Asthenia—Dexamethasone—psoriatic arthritis	9.93e-05	0.000815	CcSEcCtD
Hydroxyurea—Asthenia—Betamethasone—psoriatic arthritis	9.93e-05	0.000815	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—psoriatic arthritis	9.88e-05	0.000811	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—psoriatic arthritis	9.87e-05	0.000809	CcSEcCtD
Hydroxyurea—Nausea—Prednisolone—psoriatic arthritis	9.86e-05	0.000809	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—psoriatic arthritis	9.79e-05	0.000803	CcSEcCtD
Hydroxyurea—Vomiting—Triamcinolone—psoriatic arthritis	9.7e-05	0.000796	CcSEcCtD
Hydroxyurea—Vomiting—Methylprednisolone—psoriatic arthritis	9.68e-05	0.000794	CcSEcCtD
Hydroxyurea—Rash—Triamcinolone—psoriatic arthritis	9.62e-05	0.000789	CcSEcCtD
Hydroxyurea—Dermatitis—Triamcinolone—psoriatic arthritis	9.61e-05	0.000789	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—psoriatic arthritis	9.6e-05	0.000788	CcSEcCtD
Hydroxyurea—Rash—Methylprednisolone—psoriatic arthritis	9.6e-05	0.000788	CcSEcCtD
Hydroxyurea—Dermatitis—Methylprednisolone—psoriatic arthritis	9.59e-05	0.000787	CcSEcCtD
Hydroxyurea—Headache—Triamcinolone—psoriatic arthritis	9.56e-05	0.000784	CcSEcCtD
Hydroxyurea—Headache—Methylprednisolone—psoriatic arthritis	9.54e-05	0.000782	CcSEcCtD
Hydroxyurea—Body temperature increased—Prednisone—psoriatic arthritis	9.53e-05	0.000782	CcSEcCtD
Hydroxyurea—Diarrhoea—Dexamethasone—psoriatic arthritis	9.47e-05	0.000777	CcSEcCtD
Hydroxyurea—Diarrhoea—Betamethasone—psoriatic arthritis	9.47e-05	0.000777	CcSEcCtD
Hydroxyurea—Dizziness—Dexamethasone—psoriatic arthritis	9.15e-05	0.000751	CcSEcCtD
Hydroxyurea—Dizziness—Betamethasone—psoriatic arthritis	9.15e-05	0.000751	CcSEcCtD
Hydroxyurea—Nausea—Triamcinolone—psoriatic arthritis	9.06e-05	0.000744	CcSEcCtD
Hydroxyurea—Nausea—Methylprednisolone—psoriatic arthritis	9.04e-05	0.000742	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—psoriatic arthritis	8.98e-05	0.000737	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—psoriatic arthritis	8.96e-05	0.000735	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—psoriatic arthritis	8.88e-05	0.000729	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—psoriatic arthritis	8.87e-05	0.000728	CcSEcCtD
Hydroxyurea—Vomiting—Betamethasone—psoriatic arthritis	8.8e-05	0.000722	CcSEcCtD
Hydroxyurea—Vomiting—Dexamethasone—psoriatic arthritis	8.8e-05	0.000722	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—psoriatic arthritis	8.76e-05	0.000719	CcSEcCtD
Hydroxyurea—Rash—Betamethasone—psoriatic arthritis	8.73e-05	0.000716	CcSEcCtD
Hydroxyurea—Rash—Dexamethasone—psoriatic arthritis	8.73e-05	0.000716	CcSEcCtD
Hydroxyurea—Dermatitis—Betamethasone—psoriatic arthritis	8.72e-05	0.000716	CcSEcCtD
Hydroxyurea—Dermatitis—Dexamethasone—psoriatic arthritis	8.72e-05	0.000716	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	8.7e-05	0.000714	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—psoriatic arthritis	8.69e-05	0.000713	CcSEcCtD
Hydroxyurea—Headache—Dexamethasone—psoriatic arthritis	8.67e-05	0.000712	CcSEcCtD
Hydroxyurea—Headache—Betamethasone—psoriatic arthritis	8.67e-05	0.000712	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—psoriatic arthritis	8.65e-05	0.00071	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—psoriatic arthritis	8.62e-05	0.000707	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—psoriatic arthritis	8.3e-05	0.000681	CcSEcCtD
Hydroxyurea—Diarrhoea—Prednisone—psoriatic arthritis	8.25e-05	0.000677	CcSEcCtD
Hydroxyurea—Nausea—Betamethasone—psoriatic arthritis	8.22e-05	0.000675	CcSEcCtD
Hydroxyurea—Nausea—Dexamethasone—psoriatic arthritis	8.22e-05	0.000675	CcSEcCtD
Hydroxyurea—Dizziness—Prednisone—psoriatic arthritis	7.97e-05	0.000654	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—psoriatic arthritis	7.97e-05	0.000654	CcSEcCtD
Hydroxyurea—Vomiting—Prednisone—psoriatic arthritis	7.67e-05	0.000629	CcSEcCtD
Hydroxyurea—Rash—Prednisone—psoriatic arthritis	7.6e-05	0.000624	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—psoriatic arthritis	7.59e-05	0.000623	CcSEcCtD
Hydroxyurea—Headache—Prednisone—psoriatic arthritis	7.55e-05	0.00062	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—psoriatic arthritis	7.42e-05	0.000609	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—psoriatic arthritis	7.23e-05	0.000593	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—psoriatic arthritis	7.16e-05	0.000588	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—psoriatic arthritis	6.89e-05	0.000566	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—psoriatic arthritis	6.66e-05	0.000547	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—psoriatic arthritis	6.41e-05	0.000526	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—psoriatic arthritis	6.35e-05	0.000521	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—psoriatic arthritis	6.35e-05	0.000521	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—psoriatic arthritis	6.31e-05	0.000518	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—psoriatic arthritis	5.99e-05	0.000491	CcSEcCtD
